What have we learned from the THA trials to facilitate testing of new AChE inhibitors.
Gauthier
S
S
McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada.
Gauthier
L
L
D000544:Alzheimer Disease / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D010713:Phosphatidylcholines / Q000627:therapeutic use; D011581:Psychological Tests; D012107:Research Design; D013619:Tacrine / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D010713:Phosphatidylcholines; D013619:Tacrine